Literature DB >> 3788890

Right ventricular cardiac dysfunction in beta-thalassemia major.

A Koren, I Garty, D Antonelli, E Katzuni.   

Abstract

In patients with iron overload associated with severe, transfusion-dependent beta-thalassemia, congestive heart failure develops during the second decade of life. Biventricular heart function was studied by multigated radionuclide angiography in 22 patients with beta-thalassemia major. Six patients were symptomatic. Congestive heart failure developed in five patients at the time of blood transfusions, and one other patient had been treated for multiple ventricular extrasystole. The mean (+/- SD) left ventricular ejection fraction was normal (63.0% +/- 7.6%). Only one patient had a left ventricular ejection fraction under the normal level (less than 50%). The mean (+/- SD) right ventricular fraction (RVEF) was 33.3% +/- 9.4%. In only three patients was the RVEF normal (greater than or equal to 40%); an RVEF under 30% was registered in six patients. We suggest that the early right ventricular dysfunction in patients with beta-thalassemia may be due to pulmonary hypertension secondary to iron overload and iron deposits in the ventricles.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3788890

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  11 in total

1.  Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia.

Authors:  A Phrommintikul; A Sukonthasarn; R Kanjanavanit; W Nawarawong
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

2.  Echocardiographic and electrocardiographic prognostic factors of heart failure in young patients with beta-thalassemia major: a 10-year (1995--2004) follow-up.

Authors:  Christina Chrysohoou; Demosthenes B Panagiotakos; Yannis Barbetseas; Stella Brilli; Spyros Lambrou; Markissia Karagiorga; Vassilis A Ladis; Christos Pitsavos; Christodoulos Stefanadis
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

3.  Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin.

Authors:  Peter C Minneci; Katherine J Deans; Huang Zhi; Peter S T Yuen; Robert A Star; Steven M Banks; Alan N Schechter; Charles Natanson; Mark T Gladwin; Steven B Solomon
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

4.  PAI-1 Study in Thalassemia Major Patients Receiving Multiple Blood Transfusion.

Authors:  Ashwini Kumar; H S Batra; Mithu Banerjee; S Bandyopadhyay; T K Saha; Pratibha Misra; Vivek Ambade
Journal:  Indian J Clin Biochem       Date:  2016-10-13

Review 5.  Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.

Authors:  Gregory J Kato; Mark T Gladwin; Martin H Steinberg
Journal:  Blood Rev       Date:  2006-11-07       Impact factor: 8.250

Review 6.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

Review 7.  Pulmonary hypertension in sickle cell disease: relevance to children.

Authors:  Gregory J Kato; Onyinye C Onyekwere; Mark T Gladwin
Journal:  Pediatr Hematol Oncol       Date:  2007 Apr-May       Impact factor: 1.969

8.  Early detection of myocardial dysfunction in children with beta-thalassaemia major.

Authors:  Tayfun Uçar; Talia Ileri; Semra Atalay; Zümrüt Uysal; Ercan Tutar; Mehmet Ertem
Journal:  Int J Cardiovasc Imaging       Date:  2008-12-24       Impact factor: 2.357

9.  Detection of Left Ventricular Regional Function in Asymptomatic Children with beta-Thalassemia Major by Longitudinal Strain and Strain Rate Imaging.

Authors:  Ali Bay; Osman Başpınar; Göksel Leblebisatan; Ali Seçkin Yalçın; Ahmet Irdem
Journal:  Turk J Haematol       Date:  2013-09-05       Impact factor: 1.831

10.  Distribution of serum lipids and lipoproteins in patients with beta thalassaemia major; an epidemiological study in young adults from Greece.

Authors:  Christina Chrysohoou; Demosthenes B Panagiotakos; Christos Pitsavos; Konstantina Kosma; John Barbetseas; Markisia Karagiorga; Ioannis Ladis; Christodoulos Stefanadis
Journal:  Lipids Health Dis       Date:  2004-03-15       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.